Nexgel (NXGLW) Income from Non-Controlling Interests (2023 - 2025)
Nexgel (NXGLW) reported Income from Non-Controlling Interests of $42000.0 for Q4 2025, up 61.54% on a YoY basis from $26000.0 in Q4 2024, and up 600.0% quarter-over-quarter from $6000.0 in Q3 2025.
Nexgel (NXGLW) Income from Non-Controlling Interests (2023 - 2025) Analysis & Trends
Nexgel has reported Income from Non-Controlling Interests for 3 years, with the latest figure at $42000.0 in Q4 2025.
- For the quarter ending Q4 2025, Income from Non-Controlling Interests rose 61.54% year-over-year to $42000.0; the trailing twelve-month figure through Dec 2025 stood at $107000.0 (up 159.12% YoY), and the FY2025 full-year result was $107000.0, up 158.79% from the prior year.
- Income from Non-Controlling Interests for Q4 2025 stood at $42000.0, up from $6000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $53000.0 in Q2 2023, with the low at -$94000.0 in Q2 2024.
- Historically, Income from Non-Controlling Interests has averaged -$8750.0 across 3 years, with a median of $6500.0 in 2023.
- Annual changes were most pronounced in 2024 — Income from Non-Controlling Interests plunged 2950.0% — and 2025, when it jumped 165.38%.
- Nexgel's Income from Non-Controlling Interests stood at -$89000.0 in 2023, then surged by 129.21% to $26000.0 in 2024, then surged by 61.54% to $42000.0 in 2025.
- The last three Income from Non-Controlling Interests figures came in at $42000.0 (Q4 2025), $6000.0 (Q3 2025), and $25000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 5.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 105.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Nexgel | - | - | 819,000.00 | 42,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 42,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | -61,000.00 |
| Jun 30, 2024 | -94,000.00 |
| Mar 31, 2024 | -52,000.00 |
| Dec 31, 2023 | -89,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | 53,000.00 |
| Mar 31, 2023 | 7,000.00 |